Maternal fructose intake affects transcriptome changes and programmed hypertension in offspring in later life

Nutrients

Volumn 8, Issue 12, 2016, Pages

  Tain, You Lin ^a   Chan, Julie Y H ^a   Hsu, Chien Ning ^b,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Developmental origins of health and disease (DOHaD); Developmental programming; Fructose; Hypertension; Kidney; Next generation sequencing; Reprogramming; Transcriptome

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; 6 PHOSPHOFRUCTOKINASE ISOENZYME L; ALISKIREN; EPOXIDE HYDROLASE; FORKHEAD TRANSCRIPTION FACTOR; FRUCTOSE; GLUCOSE TRANSPORTER 1; GLYCOGEN PHOSPHORYLASE; HEXOKINASE; I KAPPA B; INSULIN RECEPTOR SUBSTRATE 2; LACTATE DEHYDROGENASE; MELATONIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTOME;

FRUCTOSE METABOLISM; GENOTYPE ENVIRONMENT INTERACTION; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY HYPERTROPHY; MATERNAL NUTRITION; METABOLIC SYNDROME X; MRNA EXPRESSION ASSAY; NEXT GENERATION SEQUENCING; NONHUMAN; NUTRIGENOMICS; PROGENY; REVIEW; DRUG EFFECTS; FEMALE; GENETIC EPIGENESIS; HUMAN; PREGNANCY; PRENATAL EXPOSURE;

EPIGENESIS, GENETIC; FEMALE; FRUCTOSE; HUMANS; HYPERTENSION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; TRANSCRIPTOME;

EID: 84997206866     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8120757     Document Type: Review

References (52)

1. Johnson, R.J.; Segal, M.S.; Sautin, Y.; Nakagawa, T.; Feig, D.I.; Kang, D.H.; Gersch, M.S.; Benner, S.; Sánchez-Lozada, L.G. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007, 86, 899-906. [PubMed]
2. Marriott, B.P.; Cole, N.; Lee, E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J. Nutr. 2009, 139, 1228S-1235S. [CrossRef] [PubMed]
3. Egan, B.M.; Zhao, Y.; Axon, R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010, 303, 2043-2050. [CrossRef] [PubMed]
4. Haugen, A.C.; Schug, T.T.; Collman, G.; Heindel, J.J. Evolution of DOHaD: The impact of environmental health sciences. J. Dev. Orig. Health Dis. 2015, 6, 55-64. [CrossRef] [PubMed]
5. Bagby, S.P. Maternal nutrition, low nephron number, and hypertension in later life: Pathways of nutritional programming. J. Nutr. 2007, 137, 1066-1072. [PubMed]
6. Kett, M.M.; Denton, K.M. Renal programming: Cause for concern? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300, R791-R803. [CrossRef] [PubMed]
7. Tain, Y.L.; Joles, J.A. Reprogramming: A preventive strategy in hypertension focusing on the kidney. Int. J. Mol. Sci. 2015, 17, E23. [CrossRef] [PubMed]
8. Tappy, L.; Lê, K.A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 2010, 90, 23-46. [CrossRef] [PubMed]
9. Chen, L.; Caballero, B.; Mitchell, D.C.; Loria, C.; Lin, P.H.; Champagne, C.M.; Elmer, P.J.; Ard, J.D.; Batch, B.C.; Anderson, C.A.; et al. Reducing consumption of sugar-sweetened beverages is associated with reduced blood pressure: A prospective study among United States adults. Circulation 2010, 121, 2398-2406. [CrossRef] [PubMed]
10. Brown, I.J.; Stamler, J.; van Horn, L.; Robertson, C.E.; Chan, Q.; Dyer, A.R.; Huang, C.C.; Rodriguez, B.L.; Zhao, L.; Daviglus, M.L.; et al. Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: International study of macro/micronutrients and blood pressure. Hypertension 2011, 57, 695-701. [CrossRef] [PubMed]
11. Brown, C.M.; Dulloo, A.G.; Yepuri, G.; Montani, J.P. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294, R730-R737. [CrossRef] [PubMed]
12. Perez-Pozo, S.E.; Schold, J.; Nakagawa, T.; Sánchez-Lozada, L.G.; Johnson, R.J.; Lillo, J.L. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: Role of uric acid in the hypertensive response. Int. J. Obes. 2010, 34, 454-461. [CrossRef] [PubMed]
13. Le, M.T.; Frye, R.F.; Rivard, C.J.; Cheng, J.; McFann, K.K.; Segal, M.S.; Johnson, R.J.; Johnson, J.A. Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism 2012, 61, 641-651. [CrossRef] [PubMed]
14. Johnson, R.J.; Sanchez-Lozada, L.G.; Nakagawa, T. The effect of fructose on renal biology and disease. J. Am. Soc. Nephrol. 2010, 21, 2036-2039. [CrossRef] [PubMed]
15. Karalius, V.P.; Shoham, D.A. Dietary sugar and artificial sweetener intake and chronic kidney disease: A review. Adv. Chronic Kidney Dis. 2013, 20, 157-164. [CrossRef] [PubMed]
16. Tran, L.T.; Yuen, V.G.; McNeill, J.H. The fructose-fed rat: A review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol. Cell Biochem. 2009, 332, 145-159. [CrossRef] [PubMed]
17. Kelishadi, R.; Mansourian, M.; Heidari-Beni, M. Association of fructose consumption and components of metabolic syndrome in human studies: A systematic review and meta-analysis. Nutrition 2014, 30, 503-510. [CrossRef] [PubMed]
18. Jayalath, V.H.; de Souza, R.J.; Ha, V.; Mirrahimi, A.; Blanco-Mejia, S.; Di Buono, M.; Jenkins, A.L.; Leiter, L.A.; Wolever, T.M.; Beyene, J.; et al. Sugar-sweetened beverage consumption and incident hypertension: A systematic review and meta-analysis of prospective cohorts. Am. J. Clin. Nutr. 2015, 102, 914-921. [CrossRef] [PubMed]
19. Toop, C.R.; Gentili, S. Fructose beverage consumption induces a metabolic syndrome phenotype in the rat: A systematic review and meta-analysis. Nutrients 2016, 8, E577. [CrossRef] [PubMed]
20. Glushakova, O.; Kosugi, T.; Roncal, C.; Mu, W.; Heinig, M.; Cirillo, P.; Sánchez-Lozada, L.G.; Johnson, R.J.; Nakagawa, T. Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J. Am. Soc. Nephrol. 2008, 19, 1712-1720. [CrossRef] [PubMed]
21. Sánchez-Lozada, L.G.; Tapia, E.; Jiménez, A.; Bautista, P.; Cristóbal, M.; Nepomuceno, T.; Soto, V.; Avila-Casado, C.; Nakagawa, T.; Johnson, R.J. et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiol. Ren. Physiol. 2007, 292, F423-F429. [CrossRef] [PubMed]
22. Klein, A.V.; Kiat, H. The mechanisms underlying fructose-induced hypertension: A review. J. Hypertens. 2015, 33, 912-920. [CrossRef] [PubMed]
23. Madero, M.; Perez-Pozo, S.E.; Jalal, D.; Johnson, R.J.; Sánchez-Lozada, L.G. Dietary fructose and hypertension. Curr. Hypertens. Rep. 2011, 13, 29-35. [CrossRef] [PubMed]
24. Regnault, T.R.; Gentili, S.; Sarr, O.; Toop, C.R.; Sloboda, D.M. Fructose, pregnancy and later life impacts. Clin. Exp. Pharmacol. Physiol. 2013, 40, 824-837. [CrossRef] [PubMed]
25. Dornas, W.C.; de Lima, W.G.; Pedrosa, M.L.; Silva, M.E. Health implications of high-fructose intake and current research. Adv. Nutr. 2015, 6, 729-737. [CrossRef] [PubMed]
26. Gray, C.; Gardiner, S.M.; Elmes, M.; Gardner, D.S. Excess maternal salt or fructose intake programmes sex-specific, stress-and fructose-sensitive hypertension in the offspring. Br. J. Nutr. 2016, 115, 594-604. [CrossRef] [PubMed]
27. Tain, Y.L.; Leu, S.; Wu, K.L.; Lee, W.C.; Chan, J.Y. Melatonin prevents maternal fructose intake-induced programmed hypertension in the offspring: Roles of nitric oxide and arachidonic acid metabolites. J. Pineal Res. 2014, 57, 80-89. [CrossRef] [PubMed]
28. Tain, Y.L.; Wu, K.L.; Lee, W.C.; Leu, S.; Chan, J.Y. Maternal fructose-intake-induced renal programming in adult male offspring. J. Nutr. Biochem. 2015, 26, 642-650. [CrossRef] [PubMed]
29. Tain, Y.L.; Lee, W.C.; Wu, K.L.; Leu, S.; Chan, J.Y. Targeting arachidonic acid pathway to prevent programmed hypertension in maternal fructose-fed male adult rat offspring. J. Nutr. Biochem. 2016, 38, 86-92. [CrossRef] [PubMed]
30. Hsu, C.N.; Wu, K.L.; Lee, W.C.; Leu, S.; Chan, J.Y.; Tain, Y.L. Aliskiren administration during early postnatal life sex-specifically alleviates hypertension programmed by maternal high fructose consumption. Front. Physiol. 2016, 7, 299. [CrossRef] [PubMed]
31. Yamada-Obara, N.; Yamagishi, S.I.; Taguchi, K.; Kaida, Y.; Yokoro, M.; Nakayama, Y.; Ando, R.; Asanuma, K.; Matsui, T.; Ueda, S. et al. Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring. Clin. Exp. Nephrol. 2016 in press. [CrossRef] [PubMed]
32. Tain, Y.L.; Lee, W.C.; Leu, S.; Wu, K.; Chan, J. High salt exacerbates programmed hypertension in maternal fructose-fed male offspring. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 1146-1151. [CrossRef] [PubMed]
33. Saad, A.F.; Dickerson, J.; Kechichian, T.B.; Yin, H.; Gamble, P.; Salazar, A.; Patrikeev, I.; Motamedi, M.; Saade, G.R.; Costantine, M.M. High-fructose diet in pregnancy leads to fetal programming of hypertension, insulin resistance, and obesity in adult offspring. Am. J. Obstet. Gynecol. 2016, 215, e1-e6. [CrossRef] [PubMed]
34. Holmberg, N.G.; Kaplan, B.; Karvonen, M.J.; Lind, J.; Malm, M. Permeability of human placenta to glucose, fructose, and xylose. Acta Physiol. Scand. 1956, 36, 291-299. [CrossRef] [PubMed]
35. Hagerman, D.D.; Roux, J.; Villee, C.A. Studies of the mechanism of fructose production by human placenta. J. Physiol. 1959, 146, 98-104. [CrossRef] [PubMed]
36. Norheim, F.; Gjelstad, I.M.; Hjorth, M.; Vinknes, K.J.; Langleite, T.M.; Holen, T.; Jensen, J.; Dalen, K.T.; Karlsen, A.S.; Kielland, A. et al. Molecular nutrition research: The modern way of performing nutritional science. Nutrients 2012, 4, 1898-1944. [CrossRef] [PubMed]
37. Meng, Q.; Ying, Z.; Noble, E.; Zhao, Y.; Agrawal, R.; Mikhail, A.; Zhuang, Y.; Tyagi, E.; Zhang, Q.; Lee, J.H. et al. Systems nutrigenomics reveals brain gene networks linking metabolic and brain disorders. EBioMedicine 2016, 7, 157-166. [CrossRef] [PubMed]
38. Chao, Y.M.; Tain, Y.L.; Leu, S.; Wu, K.L.; Lee, W.C.; Chan, J.Y. Developmental programming of the metabolic syndrome: Next-generation sequencing analysis of transcriptome expression in a rat model of maternal high fructose intake. Sheng Li Xue Bao 2016, 68, 557-567. [PubMed]
39. Efeyan, A.; Comb, W.C.; Sabatini, D.M. Nutrient-sensing mechanisms and pathways. Nature 2015, 517, 302-310. [CrossRef] [PubMed]
40. Tain, Y.L.; Hsu, C.N.; Chan, J.Y.: PPARs link early life nutritional insults to later programmed hypertension and metabolic syndrome. Int. J. Mol. Sci. 2015, 17, E20. [CrossRef] [PubMed]
41. Buffat, C.; Boubred, F.; Mondon, F.; Chelbi, S.T.; Feuerstein, J.M.; Lelièvre-Pégorier, M.; Vaiman, D.; Simeoni, U. Kidney gene expression analysis in a rat model of intrauterine growth restriction reveals massive alterations of coagulation genes. Endocrinology 2007, 148, 5549-5557. [CrossRef] [PubMed]
42. Campbell, W.B.; Falck, J.R. Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors. Hypertension 2007, 49, 590-596. [CrossRef] [PubMed]
43. Tain, Y.L.; Huang, L.T.; Chan, J.Y.; Lee, C.T. Transcriptome analysis in rat kidneys: Importance of genes involved in programmed hypertension. Int. J. Mol. Sci. 2015, 16, 4744-4758. [CrossRef] [PubMed]
44. Sloboda, D.M.; Li, M.; Patel, R.; Clayton, Z.E.; Yap, C.; Vickers, M.H.: Early life exposure to fructose and offspring phenotype: Implications for long term metabolic homeostasis. J. Obes. 2014, 2014, 203474. [CrossRef] [PubMed]
45. Paixão, A.D.; Alexander, B.T. How the kidney is impacted by the perinatal maternal environment to develop hypertension. Biol. Reprod. 2013, 89, 1-10. [CrossRef] [PubMed]
46. Tain, Y.L.; Huang, L.T.; Chan, J.Y. Transcriptional regulation of programmed hypertension by melatonin: An epigenetic perspective. Int. J. Mol. Sci. 2014, 15, 18484-18495. [CrossRef] [PubMed]
47. Lu, P.C.; Sheen, J.M.; Yu, H.R.; Lin, Y.J.; Chen, C.C.; Tiao, M.M.; Tsai, C.C.; Huang, L.T.; Tain, Y.L. Early postnatal treatment with soluble epoxide hydrolase inhibitor or 15-deoxy-D(12,14)-prostagandin J2 prevents prenatal dexamethasone and postnatal high saturated fat diet induced programmed hypertension in adult rat offspring. Prostaglandins Other Lipid Mediat. 2016, 124, 1-8. [CrossRef] [PubMed]
48. Koeners, M.P.; Wesseling, S.; Ulu, A.; Sepúlveda, R.L.; Morisseau, C.; Braam, B.; Hammock, B.D.; Joles, J.A.: Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats. Am. J. Physiol. Endocrinol. Metab. 2011, 300, E691-E698. [CrossRef] [PubMed]
49. Sherman, R.C.; Langley-Evans, S.C. Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension programmed by intrauterine exposure to a maternal low-protein diet in the rat. Clin. Sci. 1998, 94, 373-381. [CrossRef] [PubMed]
50. Sherman, R.C.; Langley-Evans, S.C. Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat. Clin. Sci. 2000, 98, 269-275. [CrossRef] [PubMed]
51. Hsu, C.N.; Lee, C.T.; Huang, L.T.; Tain, Y.L.: Aliskiren in early postnatal life prevents hypertension and reduces asymmetric dimethylarginine in offspring exposed to maternal caloric restriction. J. Renin Angiotensin Aldosterone Syst. 2015, 16, 506-513. [CrossRef] [PubMed]
52. Sandberg, K.; Ji, H. Sex differences in primary hypertension. Biol. Sex Differ. 2012, 3, 7. [CrossRef] [PubMed]